| Estimation of failure probabilities in the presence of competing risks: new representations of old estimators TA Gooley, W Leisenring, J Crowley, BE Storer Statistics in medicine 18 (6), 695-706, 1999 | 3020 | 1999 |
| CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients CJ Turtle, LA Hanafi, C Berger, TA Gooley, S Cherian, M Hudecek, ... The Journal of clinical investigation 126 (6), 2123-2138, 2016 | 2292 | 2016 |
| HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide L Luznik, PV O'Donnell, HJ Symons, AR Chen, MS Leffell, M Zahurak, ... Biology of Blood and Marrow Transplantation 14 (6), 641-650, 2008 | 2062 | 2008 |
| Reduced mortality after allogeneic hematopoietic-cell transplantation TA Gooley, JW Chien, SA Pergam, S Hingorani, ML Sorror, M Boeckh, ... New England Journal of Medicine 363 (22), 2091-2101, 2010 | 1747 | 2010 |
| Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects PA McSweeney, D Niederwieser, JA Shizuru, BM Sandmaier, AJ Molina, ... Blood, The Journal of the American Society of Hematology 97 (11), 3390-3400, 2001 | 1690 | 2001 |
| Efficacy of communication skills training for giving bad news and discussing transitions to palliative care AL Back, RM Arnold, WF Baile, KA Fryer-Edwards, SC Alexander, ... Archives of internal medicine 167 (5), 453-460, 2007 | 988 | 2007 |
| Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation JE Sanders, J Hawley, W Levy, T Gooley, CD Buckner, HJ Deeg, K Doney, ... | 908 | 1996 |
| Factors that influence collection and engraftment of autologous peripheral-blood stem cells. W Bensinger, F Appelbaum, S Rowley, R Storb, J Sanders, K Lilleby, ... Journal of Clinical Oncology 13 (10), 2547-2555, 1995 | 860 | 1995 |
| Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study M Boeckh, TA Gooley, D Myerson, T Cunningham, G Schoch, RA Bowden | 803 | 1996 |
| Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia JA Hansen, TA Gooley, PJ Martin, F Appelbaum, TR Chauncey, RA Clift, ... New England Journal of Medicine 338 (14), 962-968, 1998 | 762 | 1998 |
| Microchimerism and HLA-compatible relationships of pregnancy in scleroderma JL Nelson, DE Furst, S Maloney, T Gooley, PC Evans, A Smith, MA Bean, ... The Lancet 351 (9102), 559-562, 1998 | 745 | 1998 |
| Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient EW Petersdorf, TA Gooley, C Anasetti, PJ Martin, AG Smith, EM Mickelson, ... Blood, The Journal of the American Society of Hematology 92 (10), 3515-3520, 1998 | 611 | 1998 |
| Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood CG Brunstein, JA Gutman, DJ Weisdorf, AE Woolfrey, TE DeFor, ... Blood, The Journal of the American Society of Hematology 116 (22), 4693-4699, 2010 | 598 | 2010 |
| Generation of T-cell immunity to the HER-2/neu protein after active immunization with HER-2/neu peptide–based vaccines ML Disis, TA Gooley, K Rinn, D Davis, M Piepkorn, MA Cheever, ... Journal of Clinical Oncology 20 (11), 2624-2632, 2002 | 571 | 2002 |
| Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas OW Press, F Appelbaum, PJ Martin, DC Matthews, ID Bernstein, JF Eary, ... The Lancet 346 (8971), 336-340, 1995 | 546 | 1995 |
| High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)—seronegative recipients of stem cell transplants from seropositive donors: evidence for … WG Nichols, L Corey, T Gooley, C Davis, M Boeckh The Journal of infectious diseases 185 (3), 273-282, 2002 | 514 | 2002 |
| HLA-C–dependent prevention of leukemia relapse by donor activating KIR2DS1 JM Venstrom, G Pittari, TA Gooley, JH Chewning, S Spellman, ... New England Journal of Medicine 367 (9), 805-816, 2012 | 507 | 2012 |
| Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation MT Lin, B Storer, PJ Martin, LH Tseng, T Gooley, PJ Chen, JA Hansen New England Journal of Medicine 349 (23), 2201-2210, 2003 | 500 | 2003 |
| Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation WI Bensinger, R Clift, P Martin, FR Appelbaum, T Demirer, T Gooley, ... | 491 | 1996 |
| Cyclophosphamide metabolism, liver toxicity, and mortality following hematopoietic stem cell transplantation GB McDonald, JT Slattery, ME Bouvier, S Ren, AL Batchelder, TF Kalhorn, ... Blood, The Journal of the American Society of Hematology 101 (5), 2043-2048, 2003 | 450 | 2003 |
